Maxilase Maux De Gorge

Alpha amylase, the active ingredient in Maxilase Maux De Gorge, is an enzyme presented as an oral formulation for mouth and throat use. It catalyzes the hydrolysis of starches, which can help to reduce the viscosity of mucus and provide symptomatic relief in sore throat and related oral discomfort.

GNH USA supplies Maxilase Maux De Gorge as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets.

Maxilase Maux De Gorge, containing the enzyme alpha amylase, is used primarily in conditions affecting the oral cavity and throat where reduction of mucus viscosity is beneficial. - Sore throat (pharyngitis): may provide symptomatic relief by breaking down mucus and reducing irritation. - Mouth dryness (xerostomia): may aid in moisture retention by enzymatic breakdown of residual food particles. - Post‑operative oral discomfort: may help soothe the mucosa and facilitate clearance of secretions.

Common Side Effects: - Mild oral irritation: transient burning or tingling sensation in the mouth. - Altered taste: temporary metallic or sweet taste perception. - Nausea: occasional mild nausea after administration. - Gastrointestinal discomfort: mild abdominal cramping or loose stools.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Angioedema: swelling of lips, tongue, or throat. - Severe abdominal pain: persistent intense pain possibly indicating an adverse reaction.

Before using Maxilase Maux De Gorge, consider the following precautions: - Allergy assessment: verify no known hypersensitivity to alpha amylase or excipients. - Pediatric use: safety and efficacy have not been established in children; consult a healthcare professional. - Gastrointestinal disorders: use with caution in patients with chronic digestive conditions. - Concomitant medications: inform the prescriber of all current medicines to assess potential interactions. - Pregnancy and lactation: discuss potential risks with a physician before use. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Alpha amylase may interact with other agents that affect oral or gastrointestinal function. Major Interactions (Avoid): - Co‑administration with other oral enzymes: may increase gastrointestinal upset. - Use with antacids: can reduce enzymatic activity by altering pH. - Concurrent protease inhibitors: potential reduction in overall digestive efficiency. Moderate Interactions (Monitor Closely): - Medications causing dry mouth: may diminish the enzyme's mucosal benefits. - Anticoagulant therapy: monitor for unexpected bleeding, although no direct interaction is documented.